Radius Health Presents Positive Data for TYMLOS⢠(abaloparatide) Injection from the ACTIVExtend Trial at ASBMR 2017 Annual Meeting
(Source: GuruFocus.com) Radius’ Marketing Authorisation Application (MAA) for abaloparatide-SC for the … expectations of the significance of clinical trial data for TYMLOS, the potential …